{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:28:37Z","timestamp":1793327317920,"version":"4.5.0"},"reference-count":30,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Deanship of Research at Jordan University of Science and Technology","award":["48\/2022"],"award-info":[{"award-number":["48\/2022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Oral isotretinoin has revolutionized the treatment of severe acne vulgaris. Isotretinoin is associated with multiple adverse effects, one of which is dyslipidemia (DLP). Materials and Methods: This single-center prospective study recruited 498 patients who were eligible for isotretinoin for severe acne. Risk factors for hyperlipidemia and serum lipids were assessed at baseline. Patients received daily doses ranging from 0.25 to 1 mg\/kg of their body weight, and their fasting serum lipids were checked regularly until they reached a cumulative dose of 120\u2013150 mg\/kg. Our primary objective is to investigate dyslipidemia incidence and predictors, while the secondary objective is to assess the impact of dose reduction on lipid panels. Results: Our sample was primarily female (n = 380, 76.3%), with a normal Body Mass Index (23.2 \u00b1 4.0) and a mean age of 20.7 (\u00b14.1) years. About 72.5% had a family history of acne, 17.1% a family history of dyslipidemia. Around 17.3% reported tobacco use. A total of 57 (11.4%) patients on isotretinoin developed DLP. Smoking was independently associated with a higher risk of dyslipidemia (OR 1.97, 95% CI [1.01, 3.82], p = 0.046). The mean onset of DLP was at 3.23 (\u00b12.13) months. A total of 52 patients out of the 57 had a dose reduction of 10 mg (n = 5) or 20 mg (n = 47). A dose reduction of 50% was found to significantly improve triglyceride levels. Conclusions: More than 1 out of 10 patients on isotretinoin developed DLP. Tobacco use was significantly associated with developing DLP. Dose reduction significantly impacted a decrease in triglyceride levels.<\/jats:p>","DOI":"10.3390\/medicina61030439","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T10:46:46Z","timestamp":1740739606000},"page":"439","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring the Incidence and Risk Factors of Dyslipidemia in Patients with Severe Acne Vulgaris on Systemic Isotretinoin Therapy: Findings from a Prospective Study"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0365-6940","authenticated-orcid":false,"given":"Jihan","family":"Muhaidat","sequence":"first","affiliation":[{"name":"Department of Dermatology, Jordan University of Science and Technology, P.O.Box 3030, Irbid 22110, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Alhuneafat","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Jordan University of Science and Technology, P.O.Box 3030, Irbid 22110, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1878-5049","authenticated-orcid":false,"given":"Rand","family":"Asfar","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Jordan University of Science and Technology, P.O.Box 3030, Irbid 22110, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4876-7406","authenticated-orcid":false,"given":"Firas","family":"Al-Qarqaz","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Jordan University of Science and Technology, P.O.Box 3030, Irbid 22110, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0244-0221","authenticated-orcid":false,"given":"Diala","family":"Alshiyab","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Jordan University of Science and Technology, P.O.Box 3030, Irbid 22110, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laith","family":"Alhuneafat","sequence":"additional","affiliation":[{"name":"Cardiovascular Division, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/jfmpc.jfmpc_104_16","article-title":"Low-dose isotretinoin therapy and blood lipid abnormality: A case series with sixty patients","volume":"7","author":"Sarkar","year":"2018","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"582","DOI":"10.7326\/0003-4819-136-8-200204160-00007","article-title":"High risk for hyperlipidemia and the metabolic syndrome after an episode of hypertriglyceridemia during 13-cis retinoic acid therapy for acne: A pharmacogenetic study","volume":"136","author":"Rodondi","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"ref_4","first-page":"234","article-title":"Effects of oral isotretinoin on lipids and liver enzymes in acne patients","volume":"94","author":"Metin","year":"2014","journal-title":"Cutis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1001\/archderm.1983.01650360033009","article-title":"Changes in plasma cholesterol and triglyceride levels after treatment with oral isotretinoin","volume":"119","author":"Zech","year":"1983","journal-title":"Arch. Dermatol."},{"key":"ref_6","first-page":"355","article-title":"Changes in serum-lipoproteins and high-density-lipoprotein composition during isotretinoin therapy","volume":"10","author":"Oleary","year":"1987","journal-title":"Clin. Investig. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM197902153000701","article-title":"Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid","volume":"300","author":"Peck","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"ref_8","first-page":"S3","article-title":"The Use of Isotretinoin in the Treatment of Acne Vulgaris: Clinical Considerations and Future Directions","volume":"7","author":"Leyden","year":"2014","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4161\/derm.1.3.9364","article-title":"The use of isotretinoin in acne","volume":"1","author":"Layton","year":"2009","journal-title":"Derm.-Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF03259940","article-title":"Adverse effects of retinoids","volume":"3","author":"David","year":"1988","journal-title":"Med. Toxicol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.atherosclerosis.2008.12.020","article-title":"Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women","volume":"205","author":"Herrington","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198510173131604","article-title":"Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne","volume":"313","author":"Bershad","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1590\/S0365-05962010000300006","article-title":"Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin","volume":"85","author":"Brito","year":"2010","journal-title":"An. Bras. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archderm.142.8.1016","article-title":"A Population-Based Analysis of Laboratory Abnormalities During Isotretinoin Therapy for Acne Vulgaris","volume":"142","author":"Zane","year":"2006","journal-title":"Arch. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-4362.1999.00651.x","article-title":"Treatment outcome of acne vulgaris with oral isotretinoin in 89 patients","volume":"38","author":"Ng","year":"1999","journal-title":"Int. J. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2133.1993.tb03336.x","article-title":"Isotretinoin therapy for acne vulgaris: A re-evaluation of the need for measurements of plasma lipids and liver function tests","volume":"129","author":"Barth","year":"1993","journal-title":"Br. J. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/095466301750163509","article-title":"Analysis of laboratory data in acne patients treated with isotretinoin: Is there really a need to perform routine laboratory tests?","volume":"12","author":"Alcalay","year":"2001","journal-title":"J. Dermatol. Treat."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamadermatol.2015.3091","article-title":"Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis","volume":"152","author":"Lee","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaad.2019.06.025","article-title":"The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time","volume":"82","author":"Barbieri","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/09546634.2019.1591578","article-title":"Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: Data of 704 patients with acne vulgaris","volume":"30","author":"Hayran","year":"2019","journal-title":"J. Dermatol. Treat."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Heng, A.H.S., and Chew, F.T. (2020). Systematic review of the epidemiology of acne vulgaris. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-62715-3"},{"key":"ref_22","first-page":"37","article-title":"Emerging Issues in Adult Female Acne","volume":"10","author":"Zeichner","year":"2017","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and Cardiovascular Disease","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.114.012477","article-title":"Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease","volume":"131","author":"Peterson","year":"2015","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/archderm.139.3.376","article-title":"Taking Advantage of a Side Effect of Isotretinoin","volume":"139","author":"Cortese","year":"2003","journal-title":"Arch. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/jcla.20235","article-title":"Relationship between smoking and dyslipidemia in western Chinese elderly males","volume":"22","author":"Tan","year":"2008","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Gao, H., Wang, H., Shan, G., Liu, R., Chen, H., Sun, S., and Liu, Y. (2021). Prevalence of dyslipidemia and associated risk factors among adult residents of Shenmu City, China. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0250573"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Jeong, W. (2022). Association between dual smoking and dyslipidemia in South Korean adults. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0270577"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ahj.2010.09.023","article-title":"Effects of Smoking and Smoking Cessation on Lipids and Lipoproteins: Outcomes from a Randomized Clinical Trial","volume":"161","author":"Gepner","year":"2010","journal-title":"Am. Hear. J."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Moradinazar, M., Pasdar, Y., Najafi, F., Shahsavari, S., Shakiba, E., Hamzeh, B., and Fakhri, N. (2020). Association between dyslipidemia and blood lipids concentration with smoking habits in the Kurdish population of Iran. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-08809-z"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/3\/439\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:45:00Z","timestamp":1760028300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/3\/439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["medicina61030439"],"URL":"https:\/\/doi.org\/10.3390\/medicina61030439","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}